Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 4/2015

01-12-2015 | REVIEW ARTICLE

Role of Positron Emission Tomography-Computed Tomography in Locally Advanced Breast Cancer

Authors: Pankaj Kumar Garg, Suryanarayana V. S. Deo, Rakesh Kumar

Published in: Indian Journal of Surgical Oncology | Issue 4/2015

Login to get access

Abstract

Breast cancer is the commonest cancer among women and leading cause of cancer related mortality worldwide. Locally advanced breast cancer is the common subgroup of breast cancer encountered in developing countries. The last decade witnessed the voluminous upsurge in the use of positron emission tomography-computed tomography. Its role has been evaluated in different aspects of breast cancer - diagnosing and staging the disease, assessing the therapeutic response to chemotherapy, and restaging the recurrent disease. The present review aims to delineate the current role of positron emission tomography-computed tomography in the management of locally advanced breast cancer, based on available literature.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86CrossRefPubMed
3.
go back to reference Smith JA, Andreopoulou E (2004) An overview of the status of imaging screening technology for breast cancer. Ann Oncol 15:i18–26CrossRefPubMed Smith JA, Andreopoulou E (2004) An overview of the status of imaging screening technology for breast cancer. Ann Oncol 15:i18–26CrossRefPubMed
4.
go back to reference Manohar K, Mittal BR, Bhoil A, Bhattacharya A, Singh G (2013) Role of 18 F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer. Nucl Med Commun 34:557–61CrossRefPubMed Manohar K, Mittal BR, Bhoil A, Bhattacharya A, Singh G (2013) Role of 18 F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer. Nucl Med Commun 34:557–61CrossRefPubMed
5.
go back to reference Garg PK (2014) Preoperative fluorodeoxyglucose positron emission tomography-computed tomography in papillary thyroid cancer: a futile exercise. J Int Med Res 42:243–4CrossRefPubMed Garg PK (2014) Preoperative fluorodeoxyglucose positron emission tomography-computed tomography in papillary thyroid cancer: a futile exercise. J Int Med Res 42:243–4CrossRefPubMed
6.
go back to reference Challa VR, Srivastava A, Dhar A, Parshad R, Bal C, Mohan Reddy Gona R et al (2013) Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy. Indian J Nucl Med 28:138–43CrossRefPubMedPubMedCentral Challa VR, Srivastava A, Dhar A, Parshad R, Bal C, Mohan Reddy Gona R et al (2013) Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy. Indian J Nucl Med 28:138–43CrossRefPubMedPubMedCentral
7.
go back to reference Deo SVS, Varma MC, Shukla NK (2008) Management of patients with breast cancer: are we ready in India for sentinel lymph node biopsy? Natl Med J India 21:27–30PubMed Deo SVS, Varma MC, Shukla NK (2008) Management of patients with breast cancer: are we ready in India for sentinel lymph node biopsy? Natl Med J India 21:27–30PubMed
8.
go back to reference Groheux D, Hindié E, Rubello D, Espié M, Baillet G, Giacchetti S et al (2009) Should FDG PET/CT be used for the initial staging of breast cancer? Eur J Nucl Med Mol Imaging 36:1539–42CrossRefPubMed Groheux D, Hindié E, Rubello D, Espié M, Baillet G, Giacchetti S et al (2009) Should FDG PET/CT be used for the initial staging of breast cancer? Eur J Nucl Med Mol Imaging 36:1539–42CrossRefPubMed
9.
go back to reference Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EAM et al (2008) Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med 49:1215–22CrossRefPubMed Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EAM et al (2008) Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med 49:1215–22CrossRefPubMed
10.
go back to reference Choi YJ, Shin YD, Kang YH, Lee MS, Lee MK, Cho BS et al (2012) The effects of preoperative (18)F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study. J Breast Cancer 15:441–8CrossRefPubMedPubMedCentral Choi YJ, Shin YD, Kang YH, Lee MS, Lee MK, Cho BS et al (2012) The effects of preoperative (18)F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study. J Breast Cancer 15:441–8CrossRefPubMedPubMedCentral
11.
go back to reference Jung NY, Kim SH, Kim SH, Seo YY, Oh JK, Choi HS et al (2015) Effectiveness of breast MRI and 18 F-FDG PET/CT for the preoperative staging of invasive lobular carcinoma versus ductal carcinoma. J Breast Cancer 18:63–72CrossRefPubMedPubMedCentral Jung NY, Kim SH, Kim SH, Seo YY, Oh JK, Choi HS et al (2015) Effectiveness of breast MRI and 18 F-FDG PET/CT for the preoperative staging of invasive lobular carcinoma versus ductal carcinoma. J Breast Cancer 18:63–72CrossRefPubMedPubMedCentral
12.
go back to reference Baruah BP, Goyal A, Young P, Douglas-Jones AG, Mansel RE (2010) Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer. Br J Surg 97:680–3CrossRefPubMed Baruah BP, Goyal A, Young P, Douglas-Jones AG, Mansel RE (2010) Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer. Br J Surg 97:680–3CrossRefPubMed
13.
go back to reference Sianesi M, Ceci G, Ghirarduzzi A, Del Rio P, Guazzi A, Pisanelli B et al (2009) Use of axillary ultrasonography in breast cancer: a useful tool to reduce sentinel node procedures. Ann Ital Chir 80:315–8PubMed Sianesi M, Ceci G, Ghirarduzzi A, Del Rio P, Guazzi A, Pisanelli B et al (2009) Use of axillary ultrasonography in breast cancer: a useful tool to reduce sentinel node procedures. Ann Ital Chir 80:315–8PubMed
14.
go back to reference Van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KGA, Peterse JL, Rutgers EJT et al (2006) Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 13:31–5CrossRefPubMed Van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KGA, Peterse JL, Rutgers EJT et al (2006) Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 13:31–5CrossRefPubMed
15.
go back to reference Leenders MWH, Broeders M, Croese C, Richir MC, Go HLS, Langenhorst BLM et al (2012) Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do? Breast Edinb Scotl 21:578–83CrossRef Leenders MWH, Broeders M, Croese C, Richir MC, Go HLS, Langenhorst BLM et al (2012) Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do? Breast Edinb Scotl 21:578–83CrossRef
16.
go back to reference Pritchard KI, Julian JA, Holloway CMB, McCready D, Gulenchyn KY, George R et al (2012) Prospective study of 2-[18 F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study. J Clin Oncol 30:1274–9CrossRefPubMed Pritchard KI, Julian JA, Holloway CMB, McCready D, Gulenchyn KY, George R et al (2012) Prospective study of 2-[18 F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study. J Clin Oncol 30:1274–9CrossRefPubMed
17.
go back to reference Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, Papaioannou D et al (2011) Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol 37:187–98CrossRefPubMed Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, Papaioannou D et al (2011) Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol 37:187–98CrossRefPubMed
18.
go back to reference Robertson IJ, Hand F, Kell MR (2011) FDG-PET/CT in the staging of local/regional metastases in breast cancer. Breast Edinb Scotl 20:491–4CrossRef Robertson IJ, Hand F, Kell MR (2011) FDG-PET/CT in the staging of local/regional metastases in breast cancer. Breast Edinb Scotl 20:491–4CrossRef
19.
go back to reference Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C et al (2013) 18 F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging. J Nucl Med 54:5–11CrossRefPubMed Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C et al (2013) 18 F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging. J Nucl Med 54:5–11CrossRefPubMed
20.
go back to reference Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G et al (2008) Preoperative staging of large primary breast cancer with [18 F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 26:4746–51CrossRefPubMed Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G et al (2008) Preoperative staging of large primary breast cancer with [18 F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 26:4746–51CrossRefPubMed
21.
go back to reference Mahner S, Schirrmacher S, Brenner W, Jenicke L, Habermann CR, Avril N et al (2008) Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer. Ann Oncol 19:1249–54CrossRefPubMed Mahner S, Schirrmacher S, Brenner W, Jenicke L, Habermann CR, Avril N et al (2008) Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer. Ann Oncol 19:1249–54CrossRefPubMed
22.
go back to reference Niikura N, Costelloe CM, Madewell JE, Hayashi N, Yu T-K, Liu J et al (2011) FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist 16:1111–9CrossRefPubMedPubMedCentral Niikura N, Costelloe CM, Madewell JE, Hayashi N, Yu T-K, Liu J et al (2011) FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist 16:1111–9CrossRefPubMedPubMedCentral
24.
go back to reference Rosen EL, Eubank WB, Mankoff DA (2007) FDG PET, PET/CT, and breast cancer imaging. RadioGraphics 27:S215–29CrossRefPubMed Rosen EL, Eubank WB, Mankoff DA (2007) FDG PET, PET/CT, and breast cancer imaging. RadioGraphics 27:S215–29CrossRefPubMed
25.
go back to reference Morris PG, Lynch C, Feeney JN, Patil S, Howard J, Larson SM et al (2010) Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. J Clin Oncol 28:3154–9CrossRefPubMedPubMedCentral Morris PG, Lynch C, Feeney JN, Patil S, Howard J, Larson SM et al (2010) Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. J Clin Oncol 28:3154–9CrossRefPubMedPubMedCentral
26.
go back to reference Van der Hoeven JJM, Krak NC, Hoekstra OS, Comans EFI, Boom RPA, van Geldere D et al (2004) 18 F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol 22:1253–9CrossRefPubMed Van der Hoeven JJM, Krak NC, Hoekstra OS, Comans EFI, Boom RPA, van Geldere D et al (2004) 18 F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol 22:1253–9CrossRefPubMed
27.
go back to reference Deo SVS, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J (2003) Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol 84:192–7CrossRefPubMed Deo SVS, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J (2003) Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol 84:192–7CrossRefPubMed
28.
go back to reference Ozkan E (2013) Positron emission tomography/computed tomography in locally advanced breast cancer. Exp Oncol 35:253–7PubMed Ozkan E (2013) Positron emission tomography/computed tomography in locally advanced breast cancer. Exp Oncol 35:253–7PubMed
29.
go back to reference Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L et al (2006) Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18 F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 24:5366–72CrossRefPubMed Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L et al (2006) Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18 F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 24:5366–72CrossRefPubMed
30.
go back to reference Kumar A, Kumar R, Seenu V, Gupta SD, Chawla M, Malhotra A et al (2009) The role of 18 F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol 19:1347–57CrossRefPubMed Kumar A, Kumar R, Seenu V, Gupta SD, Chawla M, Malhotra A et al (2009) The role of 18 F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol 19:1347–57CrossRefPubMed
Metadata
Title
Role of Positron Emission Tomography-Computed Tomography in Locally Advanced Breast Cancer
Authors
Pankaj Kumar Garg
Suryanarayana V. S. Deo
Rakesh Kumar
Publication date
01-12-2015
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 4/2015
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-015-0437-5

Other articles of this Issue 4/2015

Indian Journal of Surgical Oncology 4/2015 Go to the issue